Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming, oxidative stress, and pulmonary hypertension
Marissa D. Pokharel, David Marciano, Panfeng Fu, et al.
Redox Biology (2023) Vol. 64, pp. 102797-102797
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Mitochondrial network dynamics in pulmonary disease: Bridging the gap between inflammation, oxidative stress, and bioenergetics
Marissa D. Pokharel, Alejandro Garcia Flores, David Marciano, et al.
Redox Biology (2024) Vol. 70, pp. 103049-103049
Open Access | Times Cited: 35
Targeting organ-specific mitochondrial dysfunction to improve biological aging
Corina T. Madreiter‐Sokolowski, Ursula Hiden, Jelena Krstić, et al.
Pharmacology & Therapeutics (2024) Vol. 262, pp. 108710-108710
Open Access | Times Cited: 8
Mitochondrial fission produces a Warburg effect via the oxidative inhibition of prolyl hydroxylase domain-2
Xutong Sun, Manivannan Yegambaram, Qing Lü, et al.
Redox Biology (2025) Vol. 81, pp. 103529-103529
Open Access | Times Cited: 1
Redox regulation: mechanisms, biology and therapeutic targets in diseases
Bowen Li, Hui Ming, Siyuan Qin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking
Xiao-Ming Yu, Wenxiang Qin, Haijian Cai, et al.
Computers in Biology and Medicine (2023) Vol. 169, pp. 107863-107863
Closed Access | Times Cited: 19
Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism
Pei Lin, Ye Lu, Jiarong Zheng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Critical Role of Mitochondrial Fatty Acid Metabolism in Normal Cell Function and Pathological Conditions
Sergey Dikalov, Alexander Panov, Anna Dikalova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6498-6498
Open Access | Times Cited: 7
Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota
Yicheng Yang, Hanwen Zhang, Yaoyao Wang, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 6
A potential therapeutic approach for ulcerative colitis: targeted regulation of mitochondrial dynamics and mitophagy through phytochemicals
Jianping Zhou, Yanli Xi, Ting Wu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Glucose metabolism impairment in major depressive disorder
Fanhao Meng, Jing Wang, Long Wang, et al.
Brain Research Bulletin (2025) Vol. 221, pp. 111191-111191
Open Access
NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming
Zhibo Liu, Rongrong Zhu, Jinlong Liu, et al.
Cellular Signalling (2025), pp. 111594-111594
Closed Access
Mechanistic insights into the role of EGLN3 in pulmonary vascular remodeling and endothelial dysfunction
Xiaodong Deng, Qing Que, Kunchi Zhang, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
18β-Glycyrrhetinic acid improves pulmonary hypertension by regulating the vascukar non-inflammatory molecule-1/L-arginine/nitric oxide signaling pathway
Daliya Shanahati, Tao Yang, Lei Fang, et al.
European Journal of Pharmacology (2025), pp. 177382-177382
Closed Access
New LFA-1 inhibitor Orientin reduces angiotensin II-induced vascular remodeling
Yitong Wang, Ying Zhang, Xiangbo An, et al.
European Journal of Pharmacology (2025) Vol. 995, pp. 177426-177426
Open Access
Asiatic Acid and Its Derivatives: Pharmacological Insights and Application
Chaowei Liang, Yongzhi Ma, Mingyu Ding, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117429-117429
Closed Access
Emerging Mechanistic Insights and Therapeutic Strategies for Pulmonary Arterial Hypertension: A Focus on Right Ventricular Dysfunction and Novel Treatment Pathways
Masab Mansoor, Andrew Ibrahim
Biomedicines (2025) Vol. 13, Iss. 3, pp. 600-600
Open Access
Single Test‐Based Diagnosis and Subtyping of Pulmonary Hypertension Caused by Fibrosing Mediastinitis Using Plasma Metabolic Analysis
Yating Zhao, Chunmeng Ding, Hongling Su, et al.
Advanced Science (2025)
Open Access
The Role of Hydrogen Sulfide in the Regulation of the Pulmonary Vasculature in Health and Disease
Philip I. Aaronson
Antioxidants (2025) Vol. 14, Iss. 3, pp. 341-341
Open Access
Antioxidant effects of Paeoniflorin and relevant molecular mechanisms as related to a variety of diseases: A review
Yansong Lu, Lu Yin, Wei Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116772-116772
Open Access | Times Cited: 4
Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives
Ching‐Pang Chang, Ching-Wen Wu, Yijuang Chern
Neurobiology of Disease (2024), pp. 106672-106672
Open Access | Times Cited: 4
Causal association of depression, anxiety, cognitive performance, the brain cortical structure with pulmonary arterial hypertension: A Mendelian randomization study
Zeying Zhang, Shelby Kutty, Wei Peng, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 356-362
Closed Access | Times Cited: 3
Redox remodeling of central metabolism as a driving force for cellular protection, proliferation, differentiation, and dysfunction
Junichi Fujii
Free Radical Research (2024), pp. 1-24
Closed Access | Times Cited: 3
Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension
Jia Wang, Chao Liu, Shen-Shen Huang, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176492-176492
Closed Access | Times Cited: 2
A peripheral system disease—Pulmonary hypertension
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 2
Evaluating the impact of type 2 diabetes mellitus on pulmonary vascular function and the development of pulmonary fibrosis
Nhlakanipho Mzimela, Nosipho Rosebud Dimba, Aubrey Mbulelo Sosibo, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top